 NEW YORK and LONDON, Jan. 20, 2021 GLOBE NEWSWIRE -- Tiziana Life Sciences plc Nasdaq: TLSA AIM: TILS Tiziana or the Company, a biotechnology company focused on innovative therapeutics for oncology, inflammation, and infectious diseases, today provided a further update with respect to the cancellation of admission of its Ordinary Shares to trading on AIM and admission to listing of its ordinary shares the Ordinary Shares on the standard listing segment of the Official List of the Financial Conduct Authority FCA the Official List and admission to trading on the main market for listed securities the Main Market of London Stock Exchange plc the London Stock Exchange together, Admission. 